Hepatocellular carcinoma in the alcoholic

Area of Science:

• Hepatology
• Oncology
• Immunology

Background:

• Alcoholic liver disease progresses from hepatitis to cirrhosis and hepatocellular carcinoma (HCC).
• This progression is influenced by ethanol toxicity, nutritional deficiencies, immune abnormalities, and genetic predisposition.
• Viral hepatitis (e.g., hepatitis B) and other agents can accelerate liver damage.

Purpose of the Study:

• To investigate the mechanisms driving the progression of alcoholic liver disease to HCC.
• To explore the role of Mallory bodies and immune responses in liver damage and cancer development.
• To identify potential therapeutic targets for preventing HCC in alcoholic patients.

Main Methods:

• Serial liver biopsies in patients with alcoholism.
• In vitro perfusion studies of percutaneous liver biopsies to assess DNA and collagen synthesis.
• Analysis of immune responses, including hepatitis B vaccine efficacy.

Main Results:

• Mallory bodies may act as proto-oncogenes, contributing to cytotoxicity and fibrosis.
• Immune deficiency in alcoholics impairs hepatitis B vaccine response and may promote HCC.
• Studies on DNA and collagen synthesis reveal precursor lesions for HCC.

Conclusions:

• Abstinence, nutritional therapy, and anabolic drugs can facilitate liver repair and correct immune abnormalities.
• These interventions may help prevent the development of HCC in individuals with alcoholic cirrhosis.
• Understanding Mallory bodies and immune status is crucial for HCC prevention and treatment in alcoholics.